United Neuroscience to Present at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics
DUBLIN, Feb. 28, 2018 /PRNewswire/ -- United Neuroscience, Ltd., (UNS), today announced that the company will present at the upcoming 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT) conference being held March 7-10, 2018. Presentation details are as follows:
Symposium presentation: Active immunotherapy vaccines for CNS
disorders
Presenter: Ajay Verma, M.D., Ph.D., Chief Medical
Officer
Date: Friday, March 9, 2018
Time: 10:15 a.m. EST
Poster presentation: A Phase 2a, randomized, double-blind,
placebo-controlled, 3-arm parallel-group,
multicenter study with active
immunotherapeutic vaccine UB-311 in
patients with mild Alzheimer's disease
Time: Thursday, March 8, 3:45 p.m. EST and Friday,
March 9, 4:15 p.m. EST
Location: Hilton Washington D.C./Rockville Hotel,
Rockville, MD
About United Neuroscience
United Neuroscience (UNS) is a clinical-stage biotech company dedicated to the development of best-in-class immunotherapeutics for the brain. A global company headquartered in Dublin, Ireland, with operations in Taiwan and the United States, UNS was founded to address the social and economic burden of Alzheimer's and other neurodegenerative diseases and seeks to rapidly advance candidates into and through clinical trials with the goal of delivering breakthrough treatments to patients. For more information please visit www.unitedneuroscience.com. Follow UNS on Twitter at https://twitter.com/UNSTechBio and on LinkedIn at www.linkedin.com/company/unitedneuroscience.
Media Contacts
David Schull or Rich Allan
Russo Partners, LLC
(212) 845-4271
(646) 942-5588
david.schull@russopartnersllc.com
rich.allan@russopartnersllc.com
View original content: http://www.prnewswire.com/news-releases/united-neuroscience-to-present-at-the-20th-annual-meeting-of-the-american-society-for-experimental-neurotherapeutics-300605804.html
SOURCE United Neuroscience, Ltd.